CA ATC J05AG03 · updated 2 Nov 2026
Efavirenz shortage in Canada
Is there an Efavirenz shortage in Canada?
Yes. As of 2 Nov 2026, 2 Efavirenz products are reported short in Canada, the first since 14 May 2025. The company estimate for the return is 13 Jul 2027. Main reason: manufacturing problem.
Also short in Austria, New Zealand. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | TEVA-EFAVIRENZ (30) | TEVA CANADA LIMITED | 14 May 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | MYLAN-EFAVIRENZ (30BT) | MYLAN PHARMACEUTICALS ULC | 4 May 2026 | 13 Jul 2027 | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.